Joshua MLawrenzMD
Orthopaedic Surgery • Nashville, TNHip & Knee Reconstructive Surgery, Musculoskeletal Oncology/Cancer
Physician
Dr. Lawrenz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Summary
- Joshua M. Lawrenz, MD joined the Vanderbilt Orthopaedic Institute as an orthopaedic oncologist in 2020. His clinical interests include limb salvage surgery for pelvic and extremity soft tissue and bone sarcomas. In addition, he has an elective primary and revision total joint replacement practice. His current research interests include: the use of image-based machine learning in the diagnosis of musculoskeletal tumors; enhanced recovery after surgery for sarcoma; 5-day neoadjuvant radiation in soft tissue sarcoma; and, assessment of clinical outcomes through retrospective and prospective data collection using our 30+ year orthopaedic oncology patient database.
Education & Training
Vanderbilt University Medical CenterFellowship, Musculoskeletal Oncology, 2019 - 2020
Cleveland Clinic FoundationResidency, Orthopaedic Surgery, 2014 - 2019
University of Illinois College of MedicineClass of 2014
Certifications & Licensure
TN State Medical License 2020 - 2026
GA State Medical License 2024 - 2025
IN State Medical License 2024 - 2025
KY State Medical License 2024 - 2025
MS State Medical License 2024 - 2025
AL State Medical License 2024 - 2024
MI State Medical License 2019 - 2019- American Board of Orthopaedic Surgery Orthopaedic Surgery
- Join now to see all
Clinical Trials
- Enhanced Recovery After Surgery in Extremity Sarcoma Start of enrollment: 2020 Dec 14
Publications & Presentations
PubMed
- 6 citationsIs the Number of National Database Research Studies in Musculoskeletal Sarcoma Increasing, and Are These Studies Reliable?Joshua M Lawrenz, Samuel R Johnson, Katherine S Hajdu, Andrew Chi, Gabriel A Bendfeldt
Clinical Orthopaedics and Related Research. 2023-03-01 - 11 citationsLonger duration of symptoms at the time of presentation is not associated with worse survival in primary bone sarcoma.Joshua M. Lawrenz, Joseph F. Styron, Michael Parry, R. J. Grimer, Nathan W. Mesko
The Bone & Joint Journal. 2018-04-27 - 9 citationsDietary Flaxseed Oil Protects against Bleomycin-Induced Pulmonary Fibrosis in RatsJoshua Lawrenz, Betty Herndon, Afrin Kamal, Aaron Mehrer, Daniel C. Dim
Pulmonary Medicine. 2012-08-08
Press Mentions
Hypofractionated Neoadjuvant Radiation Therapy in Soft Tissue SarcomaOctober 28th, 2020
Professional Memberships
- Fellow
- Candidate Member
- Member
- Musculoskeletal Tumor SocietyActive Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
